SUPPLY AGREEMENTSupply Agreement • July 31st, 2013 • Cempra, Inc. • Pharmaceutical preparations • Toyama
Contract Type FiledJuly 31st, 2013 Company Industry JurisdictionTHIS SUPPLY AGREEMENT (the “Agreement”) is made and entered into as of May 8, 2013 (the “Effective Date”) by and between CEMPRA PHARMACEUTICALS, INC., a Delaware corporation having an address at Building Four Quadrangle, 6340 Quadrangle Drive, Suite 100, Chapel Hill, North Carolina 27517 USA (“Cempra”), and TOYAMA CHEMICAL CO., LTD., a Japanese corporation having an address at 2-5, Nishishinjuku 3-chome, Shinjuku-ku, Tokyo, 160-0023, JAPAN (“Toyama”). Cempra and Toyama may be referred to herein individually as a “Party” or collectively, as the “Parties”.
EXCLUSIVE LICENSE AND DEVELOPMENT AGREEMENTSafety Data Exchange Agreement • July 31st, 2013 • Cempra, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 31st, 2013 Company Industry JurisdictionTHIS EXCLUSIVE LICENSE AND DEVELOPMENT AGREEMENT (the “Agreement”) is entered into as of May 8, 2013 (the “Effective Date”) by and between CEMPRA PHARMACEUTICALS, INC., a Delaware corporation having an address at Building Four Quadrangle, 6340 Quadrangle Drive, Suite 100, Chapel Hill, North Carolina 27517 USA (“Cempra”), and TOYAMA CHEMICAL CO., LTD., a Japanese corporation having an address at 2-5, Nishishinjuku 3-chome, Shinjuku-ku, Tokyo 160-0023, Japan (“Toyama”). Cempra and Toyama may be referred to herein individually as a “Party” or collectively, as the “Parties.”